These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 30883385)
1. Chronic diarrhoea in adults: what not to miss. Major GAD; Gunn D Curr Opin Gastroenterol; 2019 May; 35(3):206-212. PubMed ID: 30883385 [TBL] [Abstract][Full Text] [Related]
6. The overlap between irritable bowel syndrome and organic gastrointestinal diseases. Aziz I; Simrén M Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):139-148. PubMed ID: 33189181 [TBL] [Abstract][Full Text] [Related]
7. Current and emerging drug options in the treatment of diarrhea predominant irritable bowel syndrome. Nee J; Zakari M; Lembo AJ Expert Opin Pharmacother; 2015; 16(18):2781-92. PubMed ID: 26558923 [TBL] [Abstract][Full Text] [Related]
8. Impact of bile acid malabsorption on steatorrhoea and symptoms in patients with chronic diarrhoea. Ung KA; Kilander AF; Lindgren A; Abrahamsson H Eur J Gastroenterol Hepatol; 2000 May; 12(5):541-7. PubMed ID: 10833098 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic approach to chronic diarrhoea and recent insights in treatment of functional diarrhoea including irritable bowel syndrome. Poortmans P; Kindt S Acta Gastroenterol Belg; 2020; 83(3):461-474. PubMed ID: 33094595 [TBL] [Abstract][Full Text] [Related]
10. Emerging treatments in neurogastroenterology: eluxadoline - a new therapeutic option for diarrhea-predominant IBS. Lacy BE Neurogastroenterol Motil; 2016 Jan; 28(1):26-35. PubMed ID: 26690872 [TBL] [Abstract][Full Text] [Related]
11. Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome. Vijayvargiya P; Camilleri M; Burton D; Busciglio I; Lueke A; Donato LJ Aliment Pharmacol Ther; 2019 Mar; 49(6):744-758. PubMed ID: 30740753 [TBL] [Abstract][Full Text] [Related]
12. Chronic Diarrhea in Adults: Evaluation and Differential Diagnosis. Burgers K; Lindberg B; Bevis ZJ Am Fam Physician; 2020 Apr; 101(8):472-480. PubMed ID: 32293842 [TBL] [Abstract][Full Text] [Related]
13. Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. Camilleri M; Acosta A; Busciglio I; Boldingh A; Dyer RB; Zinsmeister AR; Lueke A; Gray A; Donato LJ Aliment Pharmacol Ther; 2015 Mar; 41(5):438-48. PubMed ID: 25594801 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis of exocrine pancreatic insufficiency from stool fat and weight. Feurle GE; Morgenstern W; Pfaff H Klin Wochenschr; 1983 Feb; 61(4):199-202. PubMed ID: 6843046 [TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin. Schröder O; Naumann M; Shastri Y; Povse N; Stein J Aliment Pharmacol Ther; 2007 Oct; 26(7):1035-42. PubMed ID: 17877510 [TBL] [Abstract][Full Text] [Related]
16. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis. Valentin N; Camilleri M; Altayar O; Vijayvargiya P; Acosta A; Nelson AD; Murad MH Gut; 2016 Dec; 65(12):1951-1959. PubMed ID: 26347530 [TBL] [Abstract][Full Text] [Related]
17. New faecal tests in gastroenterology. Ayling RM Ann Clin Biochem; 2012 Jan; 49(Pt 1):44-54. PubMed ID: 22113956 [TBL] [Abstract][Full Text] [Related]
18. Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use. Lacy BE; Chey WD; Cash BD; Lembo AJ; Dove LS; Covington PS Am J Gastroenterol; 2017 Jun; 112(6):924-932. PubMed ID: 28417992 [TBL] [Abstract][Full Text] [Related]